% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Kather:137593,
author = {J. N. Kather$^*$ and M. Suarez-Carmona$^*$ and P.
Charoentong$^*$ and C.-A. Weis and D. Hirsch and P. Bankhead
and M. Horning and D. Ferber and I. Kel and E. Herpel and S.
Schott and I. Zörnig$^*$ and J. Utikal$^*$ and A. Marx and
T. Gaiser and H. Brenner$^*$ and J. Chang-Claude$^*$ and M.
Hoffmeister$^*$ and D. Jäger$^*$ and N. Halama$^*$},
title = {{T}opography of cancer-associated immune cells in human
solid tumors.},
journal = {eLife},
volume = {7},
issn = {2050-084X},
address = {Cambridge},
publisher = {eLife Sciences Publications},
reportid = {DKFZ-2018-01473},
pages = {e36967},
year = {2018},
abstract = {Lymphoid and myeloid cells are abundant in the tumor
microenvironment, can be quantified by immunohistochemistry
and shape the disease course of human solid tumors. Yet,
there is no comprehensive understanding of spatial immune
infiltration patterns (topography) across cancer entities
and across various immune cell types. In this study, we
systematically measure the topography of multiple immune
cell types in 965 histological tissue slides from N = 177
patients in a pan-cancer cohort. We provide a definition of
inflamed (hot), non-inflamed (cold) and immune excluded
patterns and investigate how these patterns differ between
immune cell types and between cancer types. In an
independent cohort of N = 287 colorectal cancer patients, we
show that hot, cold and excluded topographies for effector
lymphocytes (CD8) and tumor-associated macrophages (CD163)
alone are not prognostic, but that a bivariate
classification system can stratify patients. Our study adds
evidence to consider immune topographies as biomarkers for
patients with solid tumors.},
cin = {D120 / G300 / C020 / C070 / G110 / L101},
ddc = {500},
cid = {I:(DE-He78)D120-20160331 / I:(DE-He78)G300-20160331 /
I:(DE-He78)C020-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)G110-20160331 / I:(DE-He78)L101-20160331},
pnm = {314 - Tumor immunology (POF3-314)},
pid = {G:(DE-HGF)POF3-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:30179157},
pmc = {pmc:PMC6133554},
doi = {10.7554/eLife.36967},
url = {https://inrepo02.dkfz.de/record/137593},
}